Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Iva Truxová, David Cibula, Radek Špíšek, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005968-e005968
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
Leisha A. Emens, Pedro Romero, Ana C. Anderson, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009063-e009063
Open Access | Times Cited: 33
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer
Junyang Song, Tian Xiao, Mingyang Li, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154739-154739
Closed Access | Times Cited: 20
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 7
LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer
Liu Jie, Changsheng Yan, Shaohua Xu
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 7
Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
Chanyuan Li, Ting Deng, Junya Cao, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1169-1169
Open Access | Times Cited: 15
A macrophage cell membrane-coated cascade-targeting photothermal nanosystem for combating intracellular bacterial infections
Jingdi Xiong, Haiqin Tang, Lizhong Sun, et al.
Acta Biomaterialia (2023) Vol. 175, pp. 293-306
Closed Access | Times Cited: 15
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Inga-Maria Launonen, Erdoğan Pekcan Erkan, Iga Niemiec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances
Yeseul Choi, Dong Hyeon Lee, Na Young Kim, et al.
Life (2024) Vol. 14, Iss. 4, pp. 443-443
Open Access | Times Cited: 5
Seeking Cells, Targeting Bacteria: A Cascade‐Targeting Bacteria‐Responsive Nanosystem for Combating Intracellular Bacterial Infections
Haiqin Tang, Wenlin Chu, Jingdi Xiong, et al.
Small (2024)
Closed Access | Times Cited: 5
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 13
Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness
Akpedje Serena Dossou, Morgan E. Mantsch, Ammar Kapic, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1685-1685
Open Access | Times Cited: 12
Limitations and potential of immunotherapy in ovarian cancer
Sandeep Kumar, Sayanti Acharya, Mahalakshmi Karthikeyan, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression
Alyona B. Kuznetsova, Ekaterina Kolesova, Alessandro Parodi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 636-636
Open Access | Times Cited: 4
Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer
Tereza Láníčková, Michal Hensler, Lenka Kašíková, et al.
Clinical Cancer Research (2024), pp. OF1-OF17
Open Access | Times Cited: 4
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Yan-Ruide Li, Christopher Ochoa, Yichen Zhu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107952-107952
Open Access | Times Cited: 11
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
Karolina Okła
Cells (2023) Vol. 12, Iss. 14, pp. 1912-1912
Open Access | Times Cited: 10
Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
Hao Feng, Yan Zhang, Lili Shen, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
The Contribution and Perspectives of Proteomics to Epithelial Ovarian Cancer
Junrui Pei, Haifeng Qiu, Wenjia Wang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2025)
Closed Access
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
Jingfang Wang, Wenrui Zhu, Xia Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer
Oladapo O. Yeku, Minal Barve, Winston Tan, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010959-e010959
Open Access
The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials
Chenchen Xu, Jiyu Chen, Mi Tan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches
Angelo Aquino, Ornella Franzese
Cancers (2025) Vol. 17, Iss. 9, pp. 1547-1547
Open Access
Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy
Abdullah F. U. H. Saeed
Cells (2025) Vol. 14, Iss. 10, pp. 741-741
Open Access
Page 1 - Next Page

Scroll to top